Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Should all adults with varicella be prescribed antiviral treatment?

To the Editor: A previously healthy young man with a 1-day history of fever and a rash receives a clinical diagnosis of chickenpox from his general practitioner. Should he be treated with an antiviral drug such as aciclovir?

Following the inclusion of a single dose of varicella vaccine in the National Immunisation Program Schedule in 2005, the incidence of varicella (chickenpox) and its complications appears to be declining, with the total number of hospitalisations per year in Australia probably now around 400–500.1 Similar trends have been observed in the United States. In spite of the immunisation program, around 5%–10% of adults in Australia remain non-immune to varicella infection. The disease may lead to significant morbidity and mortality in otherwise healthy adolescents and adults. The main potentially serious complication is pneumonitis, particularly in people who smoke and pregnant women.

There is anecdotal evidence that otherwise healthy adolescents and adults presenting to emergency departments (EDs) with varicella are likely to receive an antiviral drug, but the same is not true in general practice. In the latest version of Therapeutic guidelines: antibiotic there is no recommendation for early (oral)…

email